Skip to main content
Premium Trial:

Request an Annual Quote

SwitchGear Providing Roche's FuGene HD Reagent

This article has been corrected to note that Fugent is the owner of the FuGene technology, not Roche as previously reported.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SwitchGear Genomics today announced it will distribute Fugent's FuGene HD transfection reagent.

The product will be offered by Switchgear as a standalone product, as well as part of the company's LightSwitch Transfection Optimization kit.

"As part of SwitchGear's commitment to providing a complete reporter assay solution, we offer an start-to-finish system that will allow researchers to perform reporter assays quickly and easily without having to do any cloning or reagent optimization," Patrick Collin, director of R&D for the Menlo Park, Calif., company, said.

Terms of the distribution agreement were not disclosed.

SwitchGear was founded in 2005 by Stanford researchers and provides products for the study of regulatory elements in the human genome.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.